De Pascale, Gennaro
 Distribuzione geografica
Continente #
NA - Nord America 6.753
EU - Europa 5.598
AS - Asia 4.962
SA - Sud America 950
AF - Africa 146
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 18.442
Nazione #
US - Stati Uniti d'America 6.550
SG - Singapore 2.174
DE - Germania 1.335
IT - Italia 1.277
CN - Cina 1.200
SE - Svezia 773
BR - Brasile 747
FR - Francia 431
VN - Vietnam 417
PL - Polonia 310
GB - Regno Unito 280
UA - Ucraina 253
IE - Irlanda 245
HK - Hong Kong 172
IN - India 166
FI - Finlandia 165
JP - Giappone 135
ID - Indonesia 133
TR - Turchia 129
BD - Bangladesh 122
RU - Federazione Russa 110
NL - Olanda 109
CA - Canada 92
AR - Argentina 81
MX - Messico 65
ES - Italia 57
AT - Austria 49
KR - Corea 47
IQ - Iraq 42
ZA - Sudafrica 41
BE - Belgio 35
PK - Pakistan 35
CO - Colombia 29
IR - Iran 27
VE - Venezuela 24
CH - Svizzera 23
SA - Arabia Saudita 23
AU - Australia 21
CZ - Repubblica Ceca 21
EC - Ecuador 19
EG - Egitto 18
LT - Lituania 17
PH - Filippine 17
CL - Cile 15
MA - Marocco 15
JO - Giordania 14
GR - Grecia 13
IL - Israele 13
UZ - Uzbekistan 13
PE - Perù 12
PT - Portogallo 12
DZ - Algeria 11
KE - Kenya 11
BG - Bulgaria 10
CI - Costa d'Avorio 10
ET - Etiopia 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
RO - Romania 9
RS - Serbia 9
UY - Uruguay 9
CR - Costa Rica 8
PY - Paraguay 8
EE - Estonia 7
MD - Moldavia 7
MK - Macedonia 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
VA - Santa Sede (Città del Vaticano) 7
EU - Europa 6
MY - Malesia 6
NP - Nepal 6
TW - Taiwan 6
AZ - Azerbaigian 5
BO - Bolivia 5
GE - Georgia 5
NI - Nicaragua 5
AM - Armenia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
HR - Croazia 4
LB - Libano 4
OM - Oman 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
GA - Gabon 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AO - Angola 2
CG - Congo 2
Totale 18.403
Città #
Singapore 1.200
Chandler 725
Ashburn 705
San Jose 679
Warsaw 254
Dublin 241
Rome 232
New York 229
Beijing 221
Milan 181
The Dalles 178
Los Angeles 171
Jacksonville 163
Hong Kong 152
Ho Chi Minh City 146
Ann Arbor 143
San Mateo 133
Nanjing 130
Hefei 126
Chicago 124
Tokyo 121
Jakarta 117
Lauterbourg 115
Munich 108
Hanoi 99
Wilmington 93
Houston 92
Dearborn 87
Fairfield 85
Dallas 84
Frankfurt am Main 84
Nürnberg 84
Boston 82
Woodbridge 82
Seattle 81
São Paulo 76
Council Bluffs 68
Helsinki 67
Izmir 64
Marseille 64
Buffalo 62
Cattolica 61
Moscow 57
Redwood City 53
London 51
Nanchang 50
North Bergen 50
Princeton 47
Boardman 46
Nuremberg 44
Lawrence 42
Seoul 41
Santa Clara 40
Hangzhou 36
St Louis 34
Denver 33
Stockholm 33
Kent 32
Bremen 31
Brooklyn 31
Orem 31
Tianjin 31
Kraków 30
Kunming 30
Brussels 29
Chennai 29
Cambridge 28
Montreal 26
Paris 26
Belo Horizonte 24
Mexico City 24
Tukwila 24
Turku 24
Augusta 23
Johannesburg 23
Lappeenranta 23
Redmond 23
Atlanta 22
Guangzhou 22
Norwalk 22
Toronto 22
Lancaster 21
Poplar 21
Pune 21
Padova 20
Phoenix 20
Brasília 19
Da Nang 19
Shanghai 19
Vienna 19
Amsterdam 18
Hebei 18
Manchester 18
Mountain View 18
Rio de Janeiro 18
Dhaka 17
Kocaeli 17
Ankara 16
Baghdad 16
Haiphong 16
Totale 9.647
Nome #
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 355
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 326
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 308
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 301
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 284
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 278
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study 264
Colistin use in critically ill patients: in search of the optimal dosing. 259
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 254
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 242
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 234
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 231
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 211
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 205
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 205
Data on the application of early coagulation support protocol in the management of major trauma patients 197
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 195
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 192
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 191
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 190
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 188
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 187
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study 186
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 185
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 184
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project 184
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 184
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 183
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 177
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19 177
Neurological involvement during legionellosis, look beyond the lung 175
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 175
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: A randomized trial 170
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 169
The importance of airway and lung microbiome in the critically ill 168
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 165
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 165
Noninvasive ventilation for the immunocompromised patient: always appropriate? 164
Sarilumab use in severe SARS-CoV-2 pneumonia 164
High vs Low PEEP in Patients With ARDS Exhibiting Intense Inspiratory Effort During Assisted Ventilation: A Randomized Crossover Trial 159
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 159
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 158
Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial 156
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 155
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 154
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 153
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 153
Neurological involvement during Legionellosis, look beyond the lung 152
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 148
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 141
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 140
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis 139
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 138
Physiological effects of awake prone position in acute hypoxemic respiratory failure 137
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 136
Lice, rodents, and many hopes: a rare disease in a young refugee 136
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 133
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 133
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review 131
CO2driven endotracheal tube cuff control in critically ill patients: A randomized controlled study 131
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 128
The place of dexmedetomidine light sedation in patients with acute brain injury 127
Prognostic value of serial (1,3)-β-d-glucan measurements in ICU patients with invasive candidiasis 126
Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality 126
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 125
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 124
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 124
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 123
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 123
Recruitment-to-inflation ratio for bedside PEEP selection in acute respiratory distress syndrome 122
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 120
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy 119
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 119
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 119
Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care 118
Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study 116
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 116
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 115
Aerosolized colistin cost-effectiveness. Response 115
Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study 115
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 115
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies 115
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 113
Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2 113
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 113
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial 113
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 111
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 111
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 111
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 110
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: A pilot study 107
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: A two-center, matched case-control study 107
The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? 106
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 106
Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy 106
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 105
Dose of colistin: a work in progress? 105
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 104
Totale 15.974
Categoria #
all - tutte 72.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/20221.124 94 75 67 70 86 59 24 168 60 72 167 182
2022/20232.181 236 271 139 300 146 240 107 204 252 110 112 64
2023/20241.383 80 288 64 60 69 201 101 97 42 79 146 156
2024/20252.842 81 70 206 131 187 118 180 138 443 280 538 470
2025/20267.517 963 239 421 829 1.269 409 1.289 394 579 525 389 211
Totale 18.683